Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma
<p>Abstract</p> <p>Background</p> <p>Toceranib phosphate (Palladia) has a reported objective response rate of 25% in both canine apocrine gland anal sac adenocarcinoma (AGASACA) and thyroid carcinoma (TC), with stable disease occurring in an additional 50-60% of dogs. T...
Main Authors: | Urie Bridget K, Russell Duncan S, Kisseberth William C, London Cheryl A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1746-6148/8/67 |
Similar Items
-
Quantification of Canine Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Tumor Specimen Shrinkage after Formalin Fixation
by: Brandan G. Wustefeld-Janssens, et al.
Published: (2022-07-01) -
A Retrospective Study of Clinical and Histopathological Features of 81 Cases of Canine Apocrine Gland Adenocarcinoma of the Anal Sac: Independent Clinical and Histopathological Risk Factors Associated with Outcome
by: Hannah Wong, et al.
Published: (2021-11-01) -
Retrospective evaluation of canine anal sac carcinoma (260 cases) in Brazil: late detection and failures in lymph node evaluation
by: Felipe N. Paiva, et al.
Published: (2023-04-01) -
Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: A retrospective study
by: Paola Valenti, et al.
Published: (2021-02-01) -
Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
by: Emanuela Maria Morello, et al.
Published: (2021-06-01)